Toggle Menu
Join our Community
Support ToI and remove
all
ads
Learn more
English
Français
עברית
Get The Daily Edition
Account
Sign In
Sign in
Join our Community
Open Search form
Toggle Menu
Israel & the Region
Jewish Times
Israel Inside
Tech Israel
Real Estate
Israel
The Blogs
Podcasts
Community
(members only)
Newsletters
The Daily Edition
What Matters Most Today
Tech Israel
Updates from Silicon Wadi
Real Estate Israel
Monthly Update
The Weekend Edition
The Best Reads of the Week
Weekly Highlights
Choice Voices From The Blogs
Partners
Atlanta
Atlanta Jewish Times
North New Jersey
The Jewish Standard
Pittsburgh
Jewish Chronicle
United Kingdom
The Jewish News
Australia
The Australian Jewish News
For Publishers
Become a Partner
Open Search form
Toggle Menu
search
Input search
Clear search input
English
Français
עברית
Latest Articles
Latest Alerts
Israel & the Region
Jewish Times
Israel Inside
Tech Israel
Real Estate
Israel
The Blogs
Podcasts
Community
(members only)
Video
Newsletters
The Daily Edition
What Matters Most Today
Tech Israel
Updates from Silicon Wadi
Real Estate Israel
Monthly Update
The Weekend Edition
The Best Reads of the Week
Weekly Highlights
Choice Voices From The Blogs
Partners
Atlanta
Atlanta Jewish Times
North New Jersey
The Jewish Standard
Pittsburgh
Jewish Chronicle
United Kingdom
The Jewish News
Australia
The Australian Jewish News
For Publishers
Become a Partner
Community
Join our community
Sign in
About The Times of Israel
Advertise on The Times of Israel
Contact us
Download our App
For IOS users
For Android users
Get the Daily Edition
submit
Follow us
© 2026 The Times of Israel , All Rights Reserved
Terms and conditions
Privacy policy
Your Privacy Rights
Input search
Clear search input
Tech Israel
Daily Updates from Silicon Wadi for
Thursday, January 26, 2017
Facebook
Twitter
View previous edition
View next edition
Suffering from missteps, drugmaker Teva struggles to heal own ills
By
Shoshanna Solomon
A constant fixture of Israelis’ saving plans, pharma firm’s shares have plummeted as its CEO embarked on aggressive acquisition adventures, wiping billions from portfolios
Top Ops
Clifton Flack
Israel cannabis: under the hood
As individual states across the US loosen their grip on decades of cannabis prohibition, the world has a front row seat to the birth, and the inevitable growing pains, of a new multi-billion dollar cannabis economy
Shoshanna Keats Jaskoll
Of ‘fascists’ and ‘libtards’
Ah, for old Facebook, where she collected debates, instead of fearing the virtual violence in her feed
At Microsoft’s BlueHat event, geeks gather to tackle cybercrime
By
Shoshanna Solomon
Investigative journalist Brian Krebs says hacks are getting meaner as teenage criminals need new highs
Ceramics shine light on ancient Greece, but collection’s cloudy history lurks
By
Ilan Ben Zion
Rare kraters and amphorae in Borowski collection go on display at Bible Lands Museum, though some ask how items made it to Jerusalem
International Holocaust Remembrance Day
How an escape from the Nazis colored the career of Harvard’s longest-serving dean
By
Rich Tenorio
Now retired, Michael Shinagel reflects on his family’s flight from Vienna and how he, a boy who didn’t know English until age 7, earned a PhD in literature
Decriminalization seen as boost for medical marijuana research
By
Shoshanna Solomon
Weed-focused private equity fund co-founder Saul Kaye predicts $1 billion invested in Israel over the next 24 months
More Headlines
Set your sights nearer: Forum urges Israel entrepreneurs to market to Arab world
By
Dov Lieber
Researchers uncover vast numbers of unknown Nazi killing fields
By
Noah Lederman
View Edition by Date
December
January 2017
February
Mo
Tu
We
Th
Fr
Sa
Su
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
The Times of Israel
TECH ISRAEL
FREE, DAILY TO YOUR INBOX
The email is either missing or invalid.
By signing up, you agree to our
terms
You hereby accept The Times of Israel
Terms of Use
and
Privacy Policy
, and you agree to receive the latest news & offers from The Times of Israel and its partners or ad sponsors.
Advertisement
Advertisement
Back to top
Never miss breaking news on Israel
Get notifications to stay updated
Stay updated
No thanks
You're subscribed
close popup
Register for free
and continue reading
Registering allows you to manage your newsletters and alerts and helps us improve your experience. It takes just a few seconds.
Already registered? Enter your email to sign in.
Email address
Please use the following structure: example@domain.com
REGISTER OR SIGN IN
Or Continue with
By registering you agree to the
terms and conditions
. Once registered, you’ll receive our Daily Edition email for free.
Send me The Times of Israel Daily Edition
back
close popup
Register to continue
Email address
Change
REGISTER
Or Continue with
back
close popup
Log in to continue
Email address
Something went wrong.
Please try again in a few minutes..
Continue
back
close popup
Sign in or Register
Email address
*
Password
*
Incorrect password. Please try again or choose an option below.
Continue
I forgot my password
/
Send me a sign in link
Or Continue with
back
close popup
Check your email
We sent an email to you at
.
It has a link that will sign you in.
Click the link in that email to complete your registration.